In this week’s issue:
- Please see attached Email from the Office of the Vice-President Research & International regarding nomination procedures for Royal Society of Canada Fellowships.
- Please see attached email from Dr. Elizabeth Cheu, highlighting resources available for CIHR New Investigator applicants. Note that applicants located at the BCCA, PHCRI, UBC Point Grey and VCHRI sites are requested to submit Appendix 2A to Dr. Cheu by October 6th. Applicants at CFRI can contact either Dr. Dawn McArthur or Dr. Tamara English to discuss options.
- Faculty of Medicine Internal Canada Research Chairs Competition (details below, reminder)
- Networks of Centres of Excellence Next CECR competition expected to launch in the fall (details below)
- amFar, The Foundation for AIDS Research ? Targeted Biomedical Research
- Hearing Foundation of Canada ? Medical Research Grants
- Glaucoma Foundation ? 2015 Research Projects
- Alex?s Lemonade Stand ? Various Opportunities
- National Blood Foundation ? Scientific Research Grants Program
- CIHR ? eHealth Innovations Partnership Program (eHIPP) ? General Info Webinar on September 29, 2014
Awards and Honours:
- Killam Postdoctoral Fellow Research Prize
- Ross Heart Hospital ? Schottenstein Cardiovascular Sciences Prize
- UBC Faculty of Medicine Continuing Professional Development ? Cancer Care Community Workshops
- Gairdner Symposium
The Faculty of Medicine (FoM) has launched an internal Canada Research Chairs (CRC) competition to fill vacant CRC Tier 1 and 2 positions who will go forward to the national CRC competition in April 2015.
Full competition details are available on the FoM Internal CRC Competition webpage.
Request for name of applicant(s) prior to Competition Deadline:
Once your Department/School has identified applicants to be nominated in the FoM Internal CRC Competition (one CRC Tier 1 and/or one CRC Tier 2), please send Lina Jung (firstname.lastname@example.org) the name of the applicant(s) before the internal competition deadline (October 27, 2014).
If you have any questions, please contact Lina Jung at email@example.com.
The NCE Secretariat expects to launch a competition for new Centres of Excellence for Commercialization and Research. Potential applicants are encouraged to start the ground work for an application as soon as possible, and to take advantage of the information and tips found in the Applicant Resources section of the NCE web site.
Note that some documents, including the competition guide, are being updated. Revised versions will be posted when the competition is officially launched. Read more or sign up for competition alerts.
LOI Deadline: October 15, 2014
amfAR, The Foundation for AIDS Research, is pleased to announce the availability of targeted support for biomedical research projects relevant to exploring the mechanisms for HIV persistence and the potential for HIV eradication.
This RFP solicits proposals relevant to exploring the mechanisms for HIV persistence and the potential for HIV eradication. Highly active antiretroviral therapy (HAART) has significantly impacted the health of individuals infected with HIV-1. However, if therapy is interrupted, there is a rapid resumption of viral replication. Understanding the mechanisms by which the virus is able to persist in the face of therapy is necessary in order to identify strategies that may interrupt viral persistence and ultimately lead to viral eradication. amfAR wishes to support basic, pre-clinical, clinical, and especially translational research exploring the mechanisms whereby HIV infection persists; the chronic nature of viral reservoirs and latency; and barriers to the eradication of HIV, with the potential goal of ultimately curing HIV infection.
Total Cost Maximum: $180,000
Please visit the amFAR website for further details and application instructions.
Deadline: October 25, 2014
The Hearing Foundation of Canada (THFC) is the largest non-governmental funding source for research in the auditory sciences in Canada. Thanks to support from donors across Canada, THFC has partnered with Canadian universities and hospitals to award more than 50 scientific and clinical research grants of up to $20,000 since 2000. THFC is proud of the projects funded through its small but thriving program.
THFC’s vision is to provide infrastructure and funding support to scientists so they can find new ways of mitigating — and perhaps reversing — the devastating effects of hearing loss. This mandate includes encouraging and supporting science and medical students who will become tomorrow’s leaders in hearing loss research.
The Hearing foundation of Canada is once again putting out a call for proposals to provide seed funding to support new research initiatives, particularly those from young investigators that have scientific merit. The primary purpose of this funding is to provide support for operating costs, rather than capital equipment. Research must be in the categories of basic or clinical research, and focus on biological and clinical projects rather than the psycho-social aspects of hearing loss.
Visit THFC website for complete details.
Deadline: November 1, 2014
The Glaucoma Foundation works to encourage and support basic and applied research in glaucoma, gain and disseminate new information about the causes and treatment of glaucoma, and further efforts to identify and develop novel approaches to preserve visual function and reverse blindness caused by glaucoma.
To that end, the foundation is accepting applications from researchers for novel research projects. In 2015, twelve-month grants of up to $40,000 will be awarded for projects related to exfoliation syndrome and exfoliation glaucoma.
Visit TGF website for further details and application instructions.
Deadline: See below
Alex’s Lemonade Stand Foundation (ALSF) is pleased to announce that grant applications are now being accepted in the following categories:
Innovation Grant Letter of Intent, Deadline: Nov. 3, 2014
Do you have a novel idea that has potential for high impact on pediatric cancer patients? Does your idea, approach, or methodology have the potential to move your research and the field in a new direction? ALSF’s Innovation Grant provides seed funding for proof-of-concept proposals. The letter of intent must be approved in order to submit a full proposal. The award is up to $125,000 annually for two years.
Young Investigator Grant – Deadline: December 15, 2014
ALSF is committed to the next generation of pediatric cancer investigators! The Young Investigator Grant provides start-up funds for new scientists at the end of their fellowship training or early in their research career. Developing an impactful line of research and a sustainable career in pediatric oncology research are key components of this grant. The award is up to $50,000 annually for two years.
Epidemiology Grants – Deadline: December 15, 2014
ALSF provides funding that will allow investigators to pursue novel and promising epidemiological approaches to understanding childhood cancers. For examples of eligible study areas please see the guidelines. This award is up to $100,000 annually for two years.
Visit the ALSF website for further details and application instructions.
Deadline: December 31, 2014
The National Blood Foundation, the philanthropic arm of the American Association of Blood Banks, has announced the availability of funding in 2015 for scientific research projects related to transfusion medicine and cellular therapies.
NBF will award grants for original investigator-initiated research in any aspect of blood banking, transfusion medicine, cellular therapies, and patient blood management. Grants will support one- or two-year projects, with a maximum award of $75,000 per grant.
Awards will not be made to increase the funding available for currently funded research projects. NBF grants are intended to provide seed funding that allows the principal investigator to enhance his/her preliminary data. This data may then be useful in applying for larger grants.
An application fee of $150 must accompany the application unless the primary investigator is an individual member of AABB.
To be eligible, applicants must be a doctor (M.D. or Ph.D.), medical technologist, or transfusion medicine or cellular therapies professional. All applicants will be considered regardless of age, race, gender, national origin, or religion.
Visit the NBF website for complete program guidelines, information about past award recipients, and application instructions.
Funding Launch: September 2014
Registration Deadline: February 3, 2015
Application Deadline: April 1, 2015
General Info Webinar (EN)
Monday September 29, 2014
10am – 1 pm
This September, the Canadian Institutes of Health Research (CIHR) will launch the eHealth Innovations Partnership Program (eHIPP
), a collaborative funding opportunity designed to create a new generation of cost-effective patient- and population-centered health care solutions. eHIPP will support partnerships between Canadian health technology companies and innovation communities local/regional healthcare delivery settings, such as hospitals, communities, school boards/post-secondary institutions ? to co-design and integrate innovative eHealth solutions that deliver real-world health care value. These funds will support pragmatic trials of new eHealth technologies in innovation community test beds that have the capacity and desire to integrate eHealth innovations into real-world service delivery.
eHIPP is the first phase of the eHealth Innovations Initiative and is co-led by the Institute for Health Services and Policy Research (IHSPR) and the Institute of Aging (IA) in conjunction with the Institute of Neurosciences, Mental Health and Addiction (INMHA); and the Institute for Human Development, Child and Youth Health (IHDCYH).
The objectives of eHIPP are to:
- Identify patient-oriented eHealth solutions that will improve health outcomes, patient experience, and lower the cost of care along the continuum for two eHIPP priority areas:
- Early identification of, and intervention for youth and adolescents (11-25 years of age) with mental health conditions
- Support of seniors with complex care needs in their homes
- Foster partnerships between innovation communities and health technology companies to co-develop and evaluate the clinical benefit and cost-effectiveness of eHealth solutions in clinical- and population health-environments; these evaluations will take the form of cluster randomized, and/or randomized controlled trials (level 1 evidence) so as to assist in the subsequent commercialization of successful innovations
eHIPP will fund individual grants of up to $1.5 million over four years, with half of this funding coming from health technology partners, economic development agencies, and other health funding agencies. CIHR will match these partnership funds on a 1:1 basis up to a maximum of $750,000. Partnership funds previously secured for innovation development are considered eligible if received within 18 months of the funding start date (July 1, 2015).
Support for Partnership Development
To facilitate the formation of partnerships between innovation communities and health technology companies, a series of regional workshops will occur during the fall and winter of 2014. Webinars will also be held during this timeframe to provide information for prospective applicants to enhance the competitiveness of their applications.
AWARDS AND HONOURS:
Internal Deadline: October 23, 2014 at 4:00pm
Established in 2011, the Killam Postdoctoral Fellow Research Prizes are awarded annually for excellence in research. Two prizes in the amount of $5,000 each will be awarded to full-time Postdoctoral Fellows at UBC in recognition of outstanding research and scholarly contributions while at UBC. All fields of research are included.
To be considered for this prize, postdoctoral fellows must be nominated by their UBC supervisor and at least one other faculty member in the postdoctoral fellow’s Faculty. The nominators will complete all documentation. Nominees must hold a full-time appointment as a postdoctoral fellow at UBC, and must have held an appointment at UBC since November 14, 2013 or earlier. Prior recipients of the Killam Postdoctoral Fellow Research Prize are ineligible to be nominated or receive the prize again.
Please visit the Faculty of Medicine Graduate and Postdoctoral Studies website for more information.
Deadline: January 31, 2015
The Ross Medical Center at Ohio State University Wexner Medical Center is accepting nominations for the 2015 Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences.
The biennial prize provides a $100,000 honorarium, national and international recognition, and support to an international leader in the clinical sciences of cardiovascular medicine, cardiothoracic surgery, or the basic sciences of molecular or cellular cardiology.
To be eligible, a nominee must be a leader in cardiovascular sciences, either a physician or biomedical scientist who has made extraordinary and sustained leadership contributions to improving health care or who has successfully pursued innovative biomedical research with demonstrated translational benefits to patient care.
Visit the Wexner Medical Center website for complete program guidelines, information about the 2013 award winner, and nomination instructions.
Dates: September to December 2014
Location: Various locations in BC : Abbotsford, Cranbrook, Nanaimo, Port Alberni, Prince George, Sechelt, Vancouver, Vernon, Williams Lake
UBC CPD has partnered with the BC Cancer Agency’s (BCCA) Screening Group and the Family Practice Oncology Network (FPON) to develop and deliver the breast, colorectal, and prostate cancer workshops to various communities across BC.
Contact: Tanuja Barker firstname.lastname@example.org
Accreditation: Up to 4.5 Mainpro-C
Cost: $45-50 ($5 discount for electronic syllabus)
Date & Time: October 27, 2014; 4? 6pm
Location: LSC2, Life Sciences Centre, 2350 Health Sciences Mall, Vancouver BC
Don’t miss this opportunity to listen to two dynamic and high profiled researchers at the 2014 Gairdner Vancouver Symposium.
This free public lecture will feature:
- James P. Allison PhD
Recipient of the Canada Gairdner International Award, 2014
?For his discovery of immune checkpoint blockade and its successful application to immune therapy of cancer?
The University of Texas MD Anderson Cancer Center
Presentation Title: ?Targeting Immune Checkpoints in Cancer Therapy: New Insights and Opportunities?
For information about Dr. Allison: http://www.gairdner.org/content/james-allison
- Salim Yusuf, DPhil, FRCPC, FRSC, O.C.
Recipient of the Canada Gairdner Wightman Award, 2014
“For his exceptional leadership in global clinical trials and population studies of cardiovascular disease that shaped best guidelines for prevention and treatment”
McMaster University and Hamilton Health Sciences
Presentation Title: TBA
To learn more about Dr. Yusuf: http://www.gairdner.org/content/salim-yusuf
More information about the symposium can be found at http://www.cmmt.ubc.ca/events/2014/10/2014-gairdner-foundation-symposium-oct-27-2014
More information about the Gairdner Foundation can be found at http://www.gairdner.org/
For questions or more information please contact Seetha at email@example.com